April 10, 2021Comments Off on Immune-Onc Therapeutics Announces First Public Presentation of Data for its Myeloid Checkpoint Inhibitor, IO-202, in Solid Tumors at AACR21
April 10, 2021Comments Off on Tallac Therapeutics Presents New Data on Toll-like Receptor Agonist Antibody Conjugate, TAC-001, at the 2021 Virtual Annual Meeting of the American Association for Cancer Research (AACR)
April 10, 2021Comments Off on Freenome Presents Data Revealing Signatures of Immune Checkpoint Inhibitor Treatment Response Found to Be Common Across Kidney, Melanoma, and Lung Cancers
April 9, 2021Comments Off on John Robinson recruits a small band of Array vets to kickstart discovery at Cogent; Syntimmune co-founder takes charge at Arch Oncology
April 9, 2021Comments Off on Covid-19 roundup: Lilly/Incyte’s Olumiant plus remdesivir combo whiffs PhIII; France recommends mixing vaccines among younger AstraZeneca recipients
